Accessibility Help | Sitemap | Contact Us | Customer Support CALL 1-800-275-4524
United States Change Country
Home  |  Conditions  |  Products  |  Clinical Evidence  |  Education and Training  |  For Patients  |  Customer Support  |  Suppliers

360° of Healing Webinar Series On Demand Videos

KCI's Professional Education department is proud to offer one hour on demand webinars to help you keep up with information and current trends on wound care.

Keeping current in wound care concepts can be difficult but is extremely important in today's technology driven treatment environment.

To download an on demand event, please click on the appropriate webinar title below.

360 Degrees of Healing Webinar Series

  • 2013

    • Epidermal Grafting using the CelluTomeTM Epidermal Harvesting System Early clinical experiences and peer-to-peer discussions

        Watch this event!

      KCI believes education is key to promoting quality of care. Keeping current in wound care concepts can be difficult but is extremely important in maximizing outcomes. KCI’s Medical Education department will be hosting a 1 hour educational webinar session on Epidermal Grafting using the CelluTomeTM Epidermal Harvesting System Early clinical experiences and peer-to-peer discussions.
      Date:
      November 26th 11:00 AM CDT
      Speakers:

      Robert S. Kirsner, MD, PhD

      University of Miami, Miller School of Medicine

      DSL# DSL# 13-0330.W

    • (Second Chance) Practical and Clinical Evidence of ABThera Therapy vs. Barker’s Vacuum Packing Technique

        Watch this event!

      Since the ABThera™ Open Abdomen Negative Pressure Therapy (OA NPT) system was launched in 2009, surgeons from 20 sites across the US have been collecting clinical data as part of a KCI funded observational, open-label study. The results of this study have just been published in the World Journal of Surgery. The study demonstrated significant differences between ABThera™ OA NPT vs. Barker’s Vacuum Packing Technique with respect to the 30-day all cause mortality rate. Join us as two of the primary investigators, Dr. Demetrios Demetriades and Dr. Michael Cheatham, discuss the results of this groundbreaking study and the potential impact on the treatment of the open abdomen.
      Date:
      July 18th 9:30 AM CDT
      Speakers:

      Demetrios Demetriades, MD, PhD, FACS

      Dr. Demetriades is a Professor of Surgery and Director of Trauma, Emergency Surgery, and SICU at the University of Southern California, Los Angeles. This is one of the largest trauma centers in the country. He has published extensively in the field of trauma and critical care [470 peer review publications, 7 books, 1 Trauma Atlas, 85 book chapters, and 5 monographs]. He has delivered nearly 400 invited lectures/visiting professorships in more than 30 countries. He is an honorary member of many national societies and serves on the editorial board of 7 journals. He served on numerous national committees, including chairman of the Committee on Trauma Education of the American College of Surgeons. He was the Scudder Orator in Trauma for the 2011 American College of Surgeons Clinical Congress. More than 100 international research fellows, from all over the world have graduated from Dr Demetriades' program over the last 15 years.

      Michael L. Cheatham, MD, FACS, FCCM

      Michael L. Cheatham, MD, FACS, FCCM, is the Director of the Surgical Intensive Care Units, Medical Director of the Department of Respiratory Therapy, and Program Director of the General Surgery Residency at Orlando Regional Medical Center, a Level I trauma center in Orlando, Florida, USA

      Dr. Cheatham is past President of the World Society of the Abdominal Compartment Syndrome (WSACS). His interest and research into the cardiopulmonary effects of increased intra-abdominal and intrathoracic pressure span almost two decades. His current research interests include intra-abdominal pressure measurement, the use of advanced hemodynamic monitoring in intra-abdominal hypertension and abdominal compartment syndrome, improved management and closure of the open abdomen, and the long-term health effects of abdominal decompression. He has published almost 200 abstracts, manuscripts, and book chapters.

      Dr. Cheatham is also active in medical missions and international disaster relief through Samaritan’s Purse and World Medical Mission, Inc. He has been volunteering his time as a short-term missionary surgeon in Africa since 1986.

      Both Drs. Demetriades and Cheatham are compensated consultants to KCI.

      DSL #13-0376

    • Managing Complex Lower Extremity Wounds with V.A.C.Ulta and V.A.C. VeraFlo Therapy

        Watch this event! | Download the handout for this webinar

      Are you dealing with challenging chronic wounds? Looking for a new way to cleanse, treat and heal these wounds? Find your answers during this informative webinar presentation.

      Dr. John Lantis will present a one-hour program reviewing key issues in the management of chronic wounds and the utilization of NPWTi as a tool to successful wound management. He will also review clinical cases and provide information on solution choices and wound care protocols for the use of V.A.C. VeraFlo Therapy as used in his practice.
      Date:
      June 19th 10:00 AM CDT
      Speaker:

      John Lantis, MD

      Dr. John Lantis attended Albany Medical College, where he graduated Cum Laude and was elected to Alpha Omega Alpha. He completed his general surgical residency at Tufts/New England Medical Center and his vascular surgery fellowship at Brigham and Women’s Hospital. He was recently named Vice Chairman of the Department of Surgery at St Luke’s-Roosevelt Hospital in New York City, where he continues in his roles Chief of Vascular and Endovascular Surgery and the Director of Surgical Clinical Research. In 2000, he began his academic affiliation with Columbia University, where he is now a full Clinical Professor of Surgery. His clinical practice spans the fields of vascular and endovascular surgery and he directs a robust clinical/research program in the field of lower extremity wound healing and tissue repair. He is published in journals such as Journal of Vascular Surgery, WOUNDS, Diabetes Care and Annals of Vascular Surgery. He currently sits on the editorial board of WOUNDS and is a reviewer for Annals of Vascular Surgery. He has been the principal investigator on more than 55 multi-center and single-center chronic wound and vascular surgery trials, which have explored the reduction in neointimal hyperplasia roles of treatments for wound closure; including negative pressure wound therapy, growth factors and skin substitutes. His basic science efforts focus on realistic animal models for translational questions. Dr. Lantis lectures extensively nationally and internationally on vascular surgery topics. The role of the active agents in the treatment of chronic wounds and the importance of management of bioburden in limb salvage.

       

      DSL#13-0139.N (5/13)

    • Negative Pressure Therapy with Instillation – Experiences in the Surgical World with V.A.C. VeraFlo™ Therapy

        Watch this event! | Download the handout for this webinar

      The V.A.C.® Negative Pressure Wound Therapy System (NPWT) has been a successful and widely used wound therapy option since 1995; however, more recently, the V.A.C.Ulta™ with V.A.C. VeraFlo™ Therapy has been introduced to stimulate granulation tissue formation at a new level.

      This one-hour webinar will discuss the value of instillation therapy as an option for the treatment of complex wounds with the V.A.C.Ulta™ Therapy System with V.A.C. VeraFlo™ Therapy. Dr. Luc Téot will review the effects of treatment with instillation therapy on 24 patients with wounds of mixed etiologies. He will discuss the patients’ clinical outcomes and the cost-effectiveness of using V.A.C.ULTA™ with V.A.C. VeraFlo™ Therapy in comparison to the more traditional V.A.C.® NPWT System.

      The V.A.C.Ulta™ Therapy System is one of the most innovative Negative Pressure Therapy System yet, so follow Dr. Téot as he shares his experiences and benefits of instillation therapy for the treatment of complex wounds.

      Date:
      May 31st 9:30 AM CDT
      Speaker:

      Dr. Luc Téot, MD

      Dr. Téot is an Associate Professor in Plastic Surgery and is the Head of the Wound Healing Unit – Burns Unit at Hospital Lapeyronie in Montpellier, France. Dr. Téot has received over 15 years of advanced medical training, as well as specialty training in Orthopedic Surgery, General and Visceral Surgery, Reconstructive and Aesthetic Surgery, and Wound Healing Reconstructive Surgery. Dr. Téot is the founding member of the French Wound Healing Society, the Scar Club, and the International Academy of Wound Technology. He has held leadership positions such as President of the European Tissue Repair Society and the President of the World Union of Wound Healing Society. Presently, Dr. Téot is the President of the European Academy of Wound Technology.

      Dr. Téot is also a member of a number of Scientific Journal Boards such as Wound Repair and Regeneration, Journal of Wound Care, International Wound Journal, International Journal on Lower Extremity Wounds, Vulnologia, Indian Wound Management Association, and Journal des Plaies et des Cicatrications. He is presently the Editor in Chief of the Journal of Wound Technology.

      DSL#13-0332.N (4/13)

    • Negative Pressure Wound Therapy with Instillation: Next Step in the Evolution of Negative Pressure

        Watch this event! | Download the handout for this webinar

      Dr. Kim a chief investigator of a recent study "on V.A.C. Veraflo™ Therapy” will be discussing research negative pressure wound therapy with and without instillation and the role of the V.A.C.Ulta™ Therapy System with V.A.C. VeraFlo™ Therapy the wound treatment protocols for his practice. Preliminary results from the study at Georgetown University will be introduced including solution and dwell time values. Join us for this exciting session on the latest in wound healing research and technology.
      Date:
      May 28th 1:00 PM CDT
      Speaker:

      Paul J. Kim

      Dr. Kim graduated from Ohio College of Podiatric Medicine in 2002 and completed his residency at Inova Fairfax Hospital, 2005. He is certified in foot and ankle surgery. He also received his Master of Science in Clinical Research Management from Arizona State University in 2012. He is currently an Associate Professor and Director of Research at MedStar Georgetown University Hospital and Georgetown University School of Medicine in Washington D.C.. He is also the chief medical officer of the Georgetown University Medical Center Academic Contract Research Organization. Dr. Kim has been the primary or secondary investigator in many research studies, presented on a variety of topics nationwide from wound management, diabetic limb salvage, diabetic foot ulcers, introduction to research and bioengineered alternative tissues to name just a few. Dr Kim has also authored books, book chapters, and numerous peer-reviewed articles and publications.

       

      DSL#13-0194.N (5/13)

    2012

    • Scientific Evidence and Clinical Experience Utilizing the New V.A.C.Ulta Negative Pressure Wound Therapy System

        Watch this event! | Download the handout for this webinar

      The V.A.C.Ulta Therapy System is an integrated wound therapy system that provides Negative Pressure Wound Therapy (NPWT) with an instillation option. It offers proven V.A.C.® NPWT as practiced today, as well as V.A.C. VeraFlo™ Therapy, consisting of V.A.C.® Therapy coupled with automated, controlled delivery and removal of topical wound solutions to the wound bed. This webinar will provide information on instillation therapy for wound management and offer insights into the clinical decision-making process for the use of this treatment for difficult-to-heal wounds. Allen Gabriel, MD will share his experience and expertise in the area of instillation therapy and review his protocols for patient selection, solution choices and therapy options. Relevant literature in the field of instillation therapy will also be examined, including an article published by Dr. Gabriel on V.A.C. VeraFlo™ Therapy. Complex cases from his plastic surgery practice documenting successful patient outcomes using V.A.C.Ulta™ Therapy for treatment of a variety of wounds, including ileostomy wound sites, dehisced incision lines, radiated and foot wounds.
      Date:
      November 14th 1:00 PM CDT
      Speaker:

      Allen Gabriel, MD

      Dr. Allen Gabriel received a Bachelor's degree in Chemistry from the University of Utah and a Doctorate in Medicine at the University of Nevada School of Medicine. He completed his Plastic Surgery residency at the Loma Linda School of Medicine and recently completed a Breast and Aesthetic Fellowship at Baptist Hospital in Nashville, TN. Currently, Dr Gabriel is a practicing physician in Vancouver, WA. Since graduating from medical school, Dr. Gabriel has conducted wound care research projects and published articles in journals including International Wound Journal, Wounds, Journal of Pediatric Surgery, Plastic Surgery, Journal of Investigative Medicine, and Bariatric Plastic Surgery. In collaboration with leading wound care experts, Drs. Niezgoda, Gupta and Dot Weir, he published “The Peri-operative Use of Vacuum Assisted Closure Therapy in Skin Grafting, Differentiating Negative Pressure Wound Therapy Devices, and Management of Wound Environment with Negative Pressure Wound Therapy.” In addition, Dr Gabriel is a national speaker and has presented at the American College of Surgeons conference, WOCN annual meeting, Bariatric Surgery conference, and Clinical Symposia on Advances in Skin and Wound Care.

      DSL #12-0687.W (11/12)

    • Managing Surgical Incisions with the Prevena Incision Management System

        Watch this event! | Download the handout for this webinar

      This one-hour session will review how developments in the world of negative pressure therapy have lead to the advancement in treatment with the Prevena Incision Management System (IMS). Relevant research on the topic, as well as the science behind its utilization, will be covered. Dr. Reddy will share his application techniques and successful cases showing how the use of Prevena Therapy has assisted him with his group of cardiothoracic patients. Dr. Agarwal will then discuss how he has utilized Prevena Therapy in his orthopedic practice.

      Date:
      November 1st 11:00 AM CDT
      Speaker:

      Seenu Reddy, MD, MBA, FACS

      Dr. Reddy He received his Medical Degree with Honors from University of Alabama School of Medicine and an MBA in Healthcare Policy from Vanderbilt University where he completed his general surgical residency and a research fellowship in Cardiac Surgery. He went on to complete a fellowship in Cardiothoracic Surgery at Emory University. He is currently the Director, Cardiac Surgery at Centennial HCA in Nashville and a Clinical Associate Professor of Cardiac Surgery at Vanderbilt University Medical Center. He has previously served as Director of Cardiac Surgery at CSR Medical Center San Antonio at CHRISTUS Health. He has served on the faculty in the Department of Cardiothoracic Surgery and as an Associate Professor of Surgery at University of Texas Health Science Center at San Antonio and as an associate in Surgery at Emory University School of Medicine.

      Dr. Reddy is Board Certified in General Surgery and in Thoracic Surgery. He has received additional training in Aortic Endovascular Surgery and is a member of the Society of Thoracic Surgeons and the Southern Thoracic Surgical Association. He serves on the STS Workforces on Practice Management and Coding and Reimbursement and his specialties include: Off-pump coronary artery bypass surgery, minimally invasive cardiac surgery, and endovascular aortic surgery. He has published numerous book chapters and articles and is involved in research on IL-18 and congestive heart failure and remodeling.

      Animesh Agarwal, MD

      Dr. Agarwal graduated with a Bachelor’s degree in Biomedical Engineering from Johns Hopkins in 1988. He then went on to pursue a Medical degree from the UT Health Science Center of San Antonio (UTHSCSA) in 1992. He completed a residency in orthopedic surgery and a fellowship in orthopedic trauma. He is currently a Professor of Orthopedic Surgery at UTHSCSA. He is also a Professor of Biomedical Engineering at UTSA. He actively practiced for the past 15 years in the realm of orthopedic trauma surgery.

      Dr. Agarwal has done numerous clinical research studies, published a multitude of journal articles, book chapters, peer reviewed abstracts and software development projects. As a speaker, he has lectured in Mexico and throughout the United States.

      DSL #12.0662 (10/12)

    • Science and Evidence Behind NPT for the Treatment of the Open Abdomen & Clinical Study Overview

        Watch this event! | Download the handout for this webinar

      Managing the open abdomen is a highly involved process with substantial challenges. This session will review the management of the open abdomen including treatment strategies dealing with infection, sepsis and fistula formation. Pre-clinical and clinical studies will be examined, as well as the use of negative pressure therapy in the management of the open abdomen. Review of the treatment of these patients with the ABThera™ Open Abdomen System will also be discussed including recent publications, application techniques, and the monitoring of these patients post therapy application. A must-see for anyone dealing with the open abdomen.

      Date:
      October 17th 11:00 AM CDT
      Speaker:

      Dr. Demetrios Demetriades, MD, PhD, FACS

      Dr. Demetriades is a Professor of Surgery and Director of Trauma, Emergency Surgery, and SICU at the Los Angeles County and University of Southern California, Los Angeles. For 3 years, Dr. Demetriades has served in the American College of Surgeons as a member of the Executive Committee and as the Chairman of the Committee on Education in Trauma of the COT. Dr. Demetriades has also held such leadership positions including the California Governor of the American College of Surgeons for 6 years; he served on the FDA Advisory Board on Blood Products.

      Dr. Demetriades has received numerous national and international awards and honorary society memberships in many countries and universities. He was selected by the Board of Regents of the American College of Surgeons to deliver the 2011 Scudder Oration in Trauma at the Clinical Congress of the American College of Surgeons. Dr. Demetriades has published 445 peer-reviewed articles, 7 books, 1 Trauma Atlas (now in its second edition), 88 book chapters and 5 monographs. He has been invited to participate at 380 lectures/visiting professorships/named lectures in more than 30 countries as well as being part of the editorial board member of 6 journals and an honorary member of many national societies in Europe, Asia and South America.

      DSL#12-0168.W

    • Managing complex wounds with enterocutaneous fistulas utilizing negative pressure wound therapy

        Watch this event! | Download the handout for this webinar

      Enterocutaneous fistulas can be challenging enough, not to mention when combined with a wound. Utilizing negative pressure wound therapy as part of your armamentarium in fistula management can offer exceptional options for wound healing. This session will help clinicians revisit etiology and pathology of enterocutaneous fistulas. Different types of fistulas will be covered as well as differing treatment regimes for use within the Long Term Acute Hospital environment and beyond. Creative and effective application.

      Date:
      September 25 11:15 AM CDT
      Speaker:

      Lydia Galarza

      Lydia Galarza received her Bachelor of Science in Nursing degree from the University of Texas at El Paso, and is alum of Sigma Theta Tau Honor Society. She began her nursing career in Critical Care at Providence Memorial Hospital and Texas Tech University Hospital in El Paso. She subsequently followed her passion in wound care and has consulted for home health agencies to promote cost effective care plans while impacting better outcomes. She has been with KCI for over 10 years and is now a part of the Medical Education Team, developing educational Programs for Medical Societies at National and World Union Global Conferences.

      DSL#12.0547

    • An Introduction to the V.A.C.Ulta Negative Pressure Wound Therapy System

        Watch this event! | Download the handout for this webinar

      Date:
      July 23rd 11:00 AM CDT
      Speaker:

      Ron Silverman, MD, FACS

      Dr. Ron Silverman is Sr. Vice President and Chief Medical Officer, KCI, as well as a currently practicing plastic surgeon at the University of Maryland Medical Center. Prior to joining KCI, Dr. Silverman was a full-time plastic surgeon at the University of Maryland for 10 years and Chief of Plastic Surgery from 2006-2010. Dr. Silverman is a Cum Laude and AOA graduate of the University of Maryland School of Medicine and did his surgical and plastic surgical training at the Harvard / Mass. General Hospital. He is currently a clinical Associate Professor of Surgery at the University of Maryland School of Medicine and an Adjunct Associate Professor in Plastic Surgery at the Johns Hopkins School of Medicine. He has authored over 60 peer-reviewed articles and textbook chapters and has been a frequent invited speaker at Scientific and Clinical Academic conferences both nationally and internationally.

      M. Chris Lessing, BS, PhD

      Chris Lessing received his BS in Bioengineering from Rice University in Houston, where he studied the effects of mechanical forces on tissue-engineered cartilage. He earned his PhD in Biomedical Engineering from Georgia Tech in Atlanta, and his thesis examined the cellular mechanisms underlying traumatic brain injury as observed using in vitro and in vivo models. Dr. Lessing has been at KCI for nearly four years and is a Senior Scientist in the Applied Sciences group in R&D. His research at KCI has supported the product development, regulatory, and marketing efforts for the V.A.C.Ulta Therapy System and Prevena Incision Management System.

      Topic Overview:

      The V.A.C.Ulta Negative Pressure Wound Therapy System is an integrated wound management system that provides V.A.C.® Therapy [negative pressure wound therapy (NPWT)] or V.A.C. VeraFlo Therapy [instillation therapy (NPWTi)]. One therapy unit provides two therapies for customizable wound healing. V.A.C. VeraFlo Therapy consists of NPWT coupled with automated, controlled delivery to and removal of topical wound treatment solutions from the wound bed. The soak time and automated volumetric delivery differentiate V.A.C. VeraFlo Therapy from other commercially available instillation systems that either provide instillation solutions under continuous flow (without a soak time) or use gravity to instill solution into the wound. This interactive webinar will review the fundamentals behind instillation therapy and current literature published on the benefits of instillation therapy. Case studies illustrating clinical considerations and optimal use scenarios will also be reviewed.

      The V.A.C.Ulta Negative Pressure Wound Therapy System is an integrated wound management system that provides V.A.C.® Therapy [negative pressure wound therapy (NPWT)] or V.A.C. VeraFlo Therapy [instillation therapy (NPWTi)] for customizable wound healing.

      V.A.C. VeraFlo Therapy consists of NPWT coupled with automated, controlled delivery to and removal of topical wound treatment solutions from the wound bed. It is for wounds that would benefit from instillation therapy.

      V.A.C. VeraFlo Therapy is differentiated from the other commercially available instillation systems by many new features. It offers automated delivery for convenience and accuracy, Fill Assist to help clinicians determine the correct instill volume, and Dressing Soak to instill wound solutions into the wound, which may allow for easier dressing removal and increased patient comfort.

      This interactive webinar will review the fundamentals behind instillation therapy and current literature published on the benefits of instillation therapy. Case studies illustrating clinical considerations and optimal use scenarios will also be reviewed.

      DSL#12-0377.US (6/12)

    • Acellular Dermal Matrices: Graftjacket® regenerative tissue matrix and Graftjacket® flowable soft tissue scaffold science and cases

      Watch this event!

      Date:
      May 1st 1:00 PM EST
      Speaker:

      Jeffrey A. Ross, DPM, MD, FACFAS

      Dr. Ross is an Associate Clinical professor at the Baylor College of Medicine in Houston, Texas. He serves as the Chief of the Diabetic Foot Clinic at Ben Taub and Quentin Meese County Hospitals. He received his DPM degree from the New York College of Podiatric Medicine, and his MD degree from the University of Health Sciences Antigua School of Medicine. He is a Diplomat of the American Board of Podiatric Surgery, and is a Fellow of the American College of Foot and Ankle Surgeons. He is also a Fellow of the American Academy of Podiatric Sports Medicine (Past President) and the American College of Sports Medicine. He is a Fellow of the American Professional Wound Care Association. He serves as the Co-Chair of the Texas Governor's Advisory Council on Physical Fitness, and is Vice-Chair of the Texas Department of State Health Services Council. He is a past member of the Texas Diabetes Council, and a former member of the Practicing Physicians Advisory Council to CMS in Washington, D.C.

      He has run 25 marathons and dozens of triathlons, and is a master ski racer. His interests are lower extremity sports medicine and diabetic wound care. He is a frequent lecturer on these subjects nationally and internationally.

      Topic Overview:

      KCI believes education is key to promoting quality of care. Keeping current in wound care concepts can be difficult but is extremely important in maximizing outcomes. The KCI Professional Education department will be hosting a one hour educational webinar session on Acellular Dermal Matrices focusing on Graftjacket® regenerative tissue matrix and Graftjacket® soft tissue scaffold science and cases. Over the past decade dermal matrices have shown increased utilization for hard to heal wounds and this session will review both science and clinical experiences surrounding this topic.

      DSL #12-0139

 


  • KCI Express
  • Share on Facebook.com
  • Share on Twitter
  • Visit our YouTube page